Paul Hershaw

Remove the requirement that employees of the federal public service must get a referral from a medical doctor before qualifying for reimbursement for physiotherapy services under the Public Service Health Care Plan. Raise awareness about the role of physiotherapy within a multidisciplinary approach to healthcare and educate policymakers on how physiotherapy can help reduce healthcare costs, support preventative care and contribute to a healthier Canadian population at all stages of life. Internationally Educated Health Professionals: Monitoring issues related to emerging needs of profession and population. Improving access to safe and effective pain management, such as physiotherapy, as an upstream response to the opioid crisis Health Human Resource Strategy: Explore opportunities to develop health human resource strategy for the profession of physiotherapy. Enable support and funding for those communities that could potentially benefit most from telerehabilitation services, including Indigenous, First Nations, Inuit and Metis and rural and remote populations, where infrastructure may presently exclude them from access (no cellular or internet service/access) Caseload Guidelines: Joint application for funding from Health Canada for Caseload Guidelines development for Physiotherapy, Occupational Therapy. and Speech Language Pathology. Canada's response to COVID-19 pandemic: ensure personal protective equipment is available to physiotherapists working in all health care settings. Canada's COVID-19 Economic Response Plan - changes to financial supports provided in response to COVID-19 pandemic to ensure physiotherapists are included in supports, regardless of business models in place. Programs of interest include Canada Emergency Response Benefit, Canada Emergency Wage Subsidy, Canada Emergency Business Account and Canada Emergency Commercial Rent Assistance program. Adult physiotherapy services covered under the Non-Insured Health Benefits program

Infrastructure - Expand opportunities for long-term investors to support infrastructure investment, including opportunities to support investment in housing. Pensions & savings plans – Engage with public office holders regarding enhancing retirement and savings security for Canadians through retirement planning, public and registered savings plans, annuities, etc. Prescription drugs - Seeking to raise awareness about prescription drug & workplace benefit coverage. Group benefits & paramedical health care – Engage with public office holders regarding health care programs and policy that may impact group benefit plans. Climate/Environment – Engagements related to the impacts of extreme weather on the health and wellness of Canadians and expanding opportunities to meet our decarbonization commitments. International relations & trade – Engage with public office holders regarding international relations as it relates to Canada’s insurance industry. This includes how best to maximize the benefits of Canada’s trade relations for the industry and broader economy. Insurance and health regulation and legislation - Engage with public office holders regarding Canada’s financial services and health care sectors, in relation to the insurance industry. This may include the industry’s governing legislation and regulations, taxation policy, administration, and related issues, guidelines & rules. Cyber security, data, and privacy – Engage with public office holders on how to ensure the safety and integrity of Canada’s insurance industry’s data and technology systems. This may include engagement on privacy legislation, policy, and technological innovation in the insurance industry.

International trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Internal trade regarding tobacco control, alcohol, products containing carcinogens and products associated with cancer. Funding for programs to be operated by the Canadian Cancer Society to advance cancer control. Canadian Partnership Against Cancer, as it relates to continued federal funding for the cancer control strategy Canada Health Transfer and health system bilateral funding agreements intended for provinces/territories to support the delivery of healthcare services Framework Convention on Tobacco Control, including protocols, guidelines and implementation Tobacco and Vaping Products Act, as it relates to regulations, implementation and enforcement Non-Smokers' Health Act including implementation and enforcement Food and Drugs Act and regulations, as it relates to nciotine replacement products Federal Tobacco Control Strategy, including all matters related to tobacco control Taxation, revenue measures, controlled products regulations, including implementation, for alcohol, tobacco control, products containing carcinogens and products associated with cancer. Communication regarding alcohol consumption guidance. Food and Drugs Act and regulations, as it relates to alcohol warning labels Food and Drugs Act and regulations, as it relates to restricting the advertising to children of foods high in sodium, sugars and saturated fat. Healthy Living - Supporting initiatives, legislation, regulation, policies, and programs that prevent cancer or improve the social determinants of health Adoption of HPV testing and increasing HPV vaccination rates Sustainable funding of the National Advisory Committee on Preventive Health Services to ensure timely, up?to?date cancer screening guidelines Equitable and timely access to cancer screening. Measures and funding related to the charitable sector generally Equitable access to care along the full cancer continuum for First Nations, Inuit and Métis communities Employment Insurance special benefit programs, including the sickness benefit and compassionate care benefit Canada Labour Code and Employment Insurance Act, as it relates to job-protected leave, employment insurance special benefits, return to work policies, and human rights protections for people affected by cancer Access to information and support to make decisions regarding end-of-life care, including Medical Assistance In Dying Supports for mental health during people's cancer journeys Implementation and funding of the National Grief Action Plan as part of the government's work on palliative care and mental health Canada Health Act as it relates to access to care, including long-term, home, and palliative care National Caregiving Strategy Financial supports for caregivers, including the Canada Caregiver Credit Implementation of the Framework on Palliative Care in Canada and integration of a palliative approach to care in our health system, including national standards and data, care provider training, research, and implementation of the National Grief Action Plan and distinctions?based frameworks for First Nations, Inuit and Métis people Setting and measuring pan-Canadian wait time benchmarks and targets and measures to address them, including addressing healthcare shortages, increased and sustainable funding for care, infrastructure and equipment, targeted strategic funding to PTs for workforce shortages, particularly in rural and remote communities. Sustained core funding for federal research agencies, improved coverage of indirect research costs, Canadian research sovereignty, strengthening capacity and the economic benefits of domestic research, research commercialization. Increasing access to care including models of care, removing barriers to care, particularly for underserved communities, using innovative approaches to improve access to care including AI to improve timely diagnosis and treatment. Issu

Discuss increasing incidents of violence against health care workers, prevention, and enforcement of existing laws. Support nursing students through targeted financial support such as paid preceptorships and federal grants. Support internationally educated nurses through establishing a collaborative, multi-stakeholder body hosted by Health Canada, to lead national strategy, planning and coordination for internationally educated nurses' registration, integration and support. Targeted funding of $1 billion as an initial investment to immediately begin to address the current health care workforce crisis experienced by provinces/territories across Canada, with funding focused on short and long-term goals. To achieve patient-centred quality care based on the WHO’s comprehensive health labour markets framework that would be acceptable to, and delivered by, the provinces/territories. Provide sustainable funding so nurses and other healthcare workers have access to mental health supports. In keeping with the recommendations of the Truth and Reconciliation Commission, establish specific targets and timelines for the admission and graduation of First Nations, Métis and Inuit health professionals in all postsecondary institutions and provide funding dedicated to indigenous nurse students. Implementing a Universal single-payer pharmacare program. Fund innovative retention and recruitment programs targeted at early-career, mid-career and late-career nurses. Establish a dedicated coordinating body to address critical health workforce data gaps based on global best practices on health workforce management. Address health workforce shortages through the implementation of a comprehensive, pan-Canadian health human resources strategy, in coordination with the provinces and territories, backed by sufficient funding and with real accountability for achieving desired health outcomes; and address critical data gaps through significantly enhancing existing health workforce data infrastructure to standardize data collection and analysis across workers, sectors and jurisdictions, with links to relevant patient information, healthcare utilization and outcome data, for more fit-for-purpose planning and tools available at the provincial, territorial, regional and training program level. In designing this, Canada should draw on global best practices in health workforce planning including in Australia and New Zealand.

Advocate for changes to facilitate adoption of auto features for retirement savings. Advocate for legislative or regulatory changes to allow for automatic features in workplace pension plans. Discussions related to the implementation of CRA Notice 344 Consultation on the National Strategy on mental health of men and boys Discussions related to Bill S-5 Connected Care for Canadians Act. FCAC direction to update complaint-handling information for insurers Discussions related to drug pricing, including decisions, policies and processes of the Patented Medicine Prices Review Board (PMPRB) Discussions related to supply and shortages of drugs in Canada, including the Multi-Stakeholder Steering Committee. Discussions related to regulatory burden, including “cutting red tape”. Impacts on Canadian insurers of proposed U.S. tax measures. Discussions relating to the efficiency and effectiveness of the financial sector regulatory system as it pertains to insurance companies. Discussing plans on the Data Collection Modernization initiative Promotion of a broader range of investments by insurance companies (e.g., farmland, timberland, fintechs) Statutory review of the Insurance Companies Act as it relates to insurance products and investments. Discussions related to the implementation of national pharmacare including bilateral agreements with provinces and territories; the committee of experts on the implementation of pharmacare and the advisory panel on bulk purchasing. Promotion of pension products, including decumulation solutions. Discussions related to the implementation of the Interpretation letter on the Canada health act related to physician equivalent services. Inter-provincial harmonization and trade barriers as it relates to insurance products. Discussions related to the financial sector policy review. Office of the Superintendent of Financial Institutions (OSFI). Guidelines related to risk management, capital and accounting for insurance companies. This includes capital charges for infrastructure investments under the LICAT. International Trade with respect to opening trade relations, regulations, foreign ownership and national treatment in foreign markets, with regards to India, Europe, China, Japan, Trans-Pacific partnership (TPP), Canada-United States-Mexico Agreement (CUSMA), Plurilateral Trade In Services Agreement (TISA) and the World Trade Organization (WTO). Work to ensure that the income tax act does not put insurance companies at a competitive disadvantage. Promotion of risk-based and principles-based regulation for financial institutions regulations. Personal Information Protection and Electronic Documents Act: seeking workable approaches to privacy rules affecting life and health insurers when the Act is updated. Income Tax Regulations (section 6(1)(f) as it relates to income tax withholding on wage loss replacement plans (disability income benefits). Income Tax Regulations, Part XIV. Income Tax Regulations, Part III: Updating income tax rules for life insurance policies. Income Tax Act, Section 146: Retirement income recommendations regarding the treatment of life insurance companies; Section 146.2 (TFSAs); Section 146.3 (RRIFs). Income Tax Act, Part VI as it relates to capital tax on financial institutions. Financing infrastructure projects, as it relates to investments by insurers Financial Transactions and Reports Analysis Centre of Canada (FINTRAC) risk-based guidance as it relates to life insurance Employment Insurance (EI) reform as it relates to disability benefits; and EI Premium Reduction Program issues. Amendments to Proceeds of Crime (Money Laundering) and Terrorist Financing rules as they affect insurance companies

Legislating Pharmacy Benefit Manager and Insurer practices in Canada US Tariffs on medication and other pharmacy products The implementation of pharmacare in Canada, with respect to the practice of pharmacy and the role of pharmacists in pharmacare The Cannabis Act, with respect to the medical cannabis regime and the role of pharmacists in dispensing and managing medical cannabis. Rural and remote student loan forgiveness expansion Regulation and complaint to the competition bureau regarding pharmacy benefit managers Proposed changes to the public service health care plan Federal investments to improve support for the pharmacy workforce Prescription drug cost containment strategies with respect to implications for the practice of pharmacy E-health specifically as it relates to the implementation of e-prescribing in Canada, including funding for Canada Infoway Prioritizing immigration of health care workers Health transfers: increased funding to Provinces and Territories for community health providers Working with Health Canada to implement measures to respond to national drug shortages, and responding to US proposals on importation Post-market surveillance of pharmaceutical products with respect to implications for the practice of pharmacy Foreign Credential recognition Program, Health Canada Health Human Resources (HHR) Strategy - working with the department to understand the entry of foreign-trained pharmacists to Canada First Nations and Inuit Health - Non-Insured Health Benefits program (NIHB) with respect to implications for the practice of pharmacy Emergency Preparedness/Pandemic Planning with respect to implications for the practice of pharmacy Funding for a Health Human Resources Strategy and mental health resources for health providers CONTROLLED DRUGS AND SUBSTANCES ACT: Amending the CDSA to add pharmacists as practitioners (Opioids)

Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacturing facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.

Discussing the value of the subsidiary OmniaBio, as soveriegn capacity that is critical to Canada's needs in the event of future pandemics or national emergency, leading to support from federal entitities that supply capital and other financial products. Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.

Enhancing the Canada Health Transfer to right-size children's health. Advocating for the development of a pan-Canadian Child Health Strategy

Lobbying for the preservation of affordable rental housing Lobbying for the development of new affordable housing, including co-operative housing. Lobbying to ensure that low-income households can continue to live affordably in federally-administered housing co-operatives after their operating agreements end with Canada Mortgage and Housing Corporation (CMHC). Lobbying for renewed low-income subsidies for federal indigenous co-operatives. Lobbying for new low-income subsidies for federal co-ops (including Section 95 program co-op housing). Lobbying for government to examine the consequences of the steady erosion of rent-geared-to-income (RGI) capacity for low-income households in existing federally administered housing providers, including co-operatives. Lobbying for energy retrofit programs for co-op housing. Lobbying around the elimination of homelessness in Canada.